Copyright
©2014 Baishideng Publishing Group Inc. All rights reserved.
World J Gastroenterol. Nov 7, 2014; 20(41): 15374-15381
Published online Nov 7, 2014. doi: 10.3748/wjg.v20.i41.15374
Published online Nov 7, 2014. doi: 10.3748/wjg.v20.i41.15374
Performance of the Montreal classification for inflammatory bowel diseases
Lieke M Spekhorst, Marijn C Visschedijk, Rudi Alberts, Eleonora A Festen, Gerard Dijkstra, Rinse K Weersma, Department of Gastroenterology and Hepatology, University of Groningen and University Medical Centre Groningen, 9700 RB Groningen, The Netherlands
Lieke M Spekhorst, Marijn C Visschedijk, Rudi Alberts, Eleonora A Festen, Department of Genetics, University of Groningen and University Medical Centre Groningen, 9700 RB Groningen, The Netherlands
Egbert-Jan van der Wouden, Department of Gastroenterology, Isala Clinics Zwolle, 8000 GK Overijssel, The Netherlands
Author contributions: Spekhorst LM and Visschedijk MC contributed both equally to this work; The study was designed by all authors and the survey was designed by Spekhorst LM, Visschedijk MC and Weersma RK; Data analysis was carried out by Spekhorst LM, Visschedijk MC and Alberts R; The first paper was drafted by Spekhorst LM and Visschedijk MC; and all authors contributed to the final manuscript.
Supported by A VIDI grant from the Netherlands Organization for Scientific Research (NWO, to Weersma RK), No. 016.136.308; an AGIKO grant from the Netherlands Organization for Scientific Research (NWO to Visschedijk MC), No. 92.003.577; MLDS grant of the Dutch Digestive Foundation, No. WO 11-72 (to Alberts R)
Correspondence to: Rinse K Weersma, MD, PhD, Professor, Department of Gastroenterology and Hepatology, University of Groningen and University Medical Centre Groningen, Hanzeplein 1, 9700 RB Groningen, The Netherlands. r.k.weersma@umcg.nl
Telephone: +31-503-610426 Fax: +31-503-619306
Received: April 28, 2014
Revised: June 30, 2014
Accepted: July 24, 2014
Published online: November 7, 2014
Revised: June 30, 2014
Accepted: July 24, 2014
Published online: November 7, 2014
Core Tip
Core tip: According to our study, the Montreal is a reliable classification system for phenotypes in inflammatory bowel disease, except for disease severity in ulcerative colitis. The inter-observer agreement for scoring Crohn’s disease severity was moderate. This highlights the need for accurate medical reporting and the use of additional parameters to define and classify disease severity. Such alternations are necessary to ensure high-quality data in multicentre prospective data collections.